M.D. Sass LLC Reduces Position in Danaher Co. (NYSE:DHR)

M.D. Sass LLC reduced its stake in Danaher Co. (NYSE:DHR) by 11.7% during the third quarter, Holdings Channel.com reports. The firm owned 176,248 shares of the conglomerate’s stock after selling 23,430 shares during the quarter. Danaher accounts for approximately 3.6% of M.D. Sass LLC’s holdings, making the stock its 15th largest position. M.D. Sass LLC’s holdings in Danaher were worth $49,000,000 as of its most recent SEC filing.

Several other institutional investors and hedge funds also recently bought and sold shares of the stock. Mount Yale Investment Advisors LLC increased its holdings in Danaher by 84.3% in the 1st quarter. Mount Yale Investment Advisors LLC now owns 1,836 shares of the conglomerate’s stock worth $459,000 after acquiring an additional 840 shares in the last quarter. Ascent Group LLC raised its position in shares of Danaher by 7.8% during the 1st quarter. Ascent Group LLC now owns 1,693 shares of the conglomerate’s stock valued at $423,000 after purchasing an additional 123 shares during the period. Waverly Advisors LLC lifted its stake in shares of Danaher by 251.1% during the 1st quarter. Waverly Advisors LLC now owns 8,774 shares of the conglomerate’s stock valued at $2,191,000 after buying an additional 6,275 shares in the last quarter. Ancora Advisors LLC boosted its holdings in Danaher by 4.6% in the 1st quarter. Ancora Advisors LLC now owns 6,898 shares of the conglomerate’s stock worth $1,723,000 after buying an additional 305 shares during the period. Finally, Tidal Investments LLC increased its stake in Danaher by 14.4% in the 1st quarter. Tidal Investments LLC now owns 52,421 shares of the conglomerate’s stock worth $13,089,000 after buying an additional 6,618 shares in the last quarter. 79.05% of the stock is currently owned by hedge funds and other institutional investors.

Analysts Set New Price Targets

DHR has been the topic of several research analyst reports. StockNews.com downgraded Danaher from a “buy” rating to a “hold” rating in a research report on Monday, November 18th. Royal Bank of Canada dropped their price target on Danaher from $333.00 to $311.00 and set an “outperform” rating for the company in a research note on Wednesday, October 23rd. Barclays reduced their price objective on shares of Danaher from $285.00 to $275.00 and set an “equal weight” rating on the stock in a research report on Wednesday, October 23rd. Wells Fargo & Company assumed coverage on shares of Danaher in a research note on Tuesday, August 27th. They set an “equal weight” rating and a $280.00 target price for the company. Finally, Raymond James dropped their price objective on shares of Danaher from $310.00 to $300.00 and set an “outperform” rating for the company in a report on Wednesday, October 23rd. Six investment analysts have rated the stock with a hold rating and fourteen have given a buy rating to the stock. Based on data from MarketBeat.com, the stock currently has a consensus rating of “Moderate Buy” and a consensus target price of $287.16.

Danaher Trading Down 1.2 %

Danaher stock traded down $2.86 during midday trading on Tuesday, reaching $234.82. The stock had a trading volume of 453,653 shares, compared to its average volume of 2,758,392. The company has a quick ratio of 1.01, a current ratio of 1.37 and a debt-to-equity ratio of 0.32. The company has a fifty day moving average of $257.38 and a 200 day moving average of $259.93. Danaher Co. has a 52-week low of $215.68 and a 52-week high of $281.70. The firm has a market cap of $169.61 billion, a price-to-earnings ratio of 45.35, a price-to-earnings-growth ratio of 4.34 and a beta of 0.85.

Danaher (NYSE:DHR) last released its earnings results on Tuesday, October 22nd. The conglomerate reported $1.71 earnings per share for the quarter, topping analysts’ consensus estimates of $1.57 by $0.14. The business had revenue of $5.80 billion for the quarter, compared to analyst estimates of $5.59 billion. Danaher had a return on equity of 10.62% and a net margin of 16.39%. The business’s revenue was up 3.1% compared to the same quarter last year. During the same quarter last year, the firm posted $2.02 earnings per share. On average, analysts anticipate that Danaher Co. will post 7.5 earnings per share for the current fiscal year.

Danaher Dividend Announcement

The business also recently declared a quarterly dividend, which was paid on Friday, October 25th. Stockholders of record on Friday, September 27th were paid a dividend of $0.27 per share. This represents a $1.08 annualized dividend and a dividend yield of 0.46%. The ex-dividend date was Friday, September 27th. Danaher’s dividend payout ratio is presently 20.61%.

Danaher Profile

Danaher Corporation designs, manufactures, and markets professional, medical, industrial, and commercial products and services worldwide. The Biotechnology segments offers bioprocess technologies, consumables, and services that advance, accelerate, and integrate the development and manufacture of therapeutics; cell line and cell culture media development services; cell culture media, process liquids and buffers for manufacturing, chromatography resins, filtration technologies, aseptic fill finish; single-use hardware and consumables and services, such as the design and installation of full manufacturing suites; lab filtration, separation, and purification; lab-scale protein purification and analytical tools; reagents, membranes, and services; and healthcare filtration solutions.